The story of Viagra and its effect on the healthcare landscape presents a thorny question for shareholders . Initially a hugely successful drug, competitors have significantly eroded its market dominance, https://arranoegb970791.blogoscience.com/48426133/the-blue-pill-and-the-pharmaceutical-sector-a-risky-venture